0

Journal Articles

in Heart Failure
 1-20 of 145 Articles
Viewpoint |  April 17, 2013
Strategies and Opportunities for Drug Development in Heart Failure
Javed Butler, MD, MPH; Gregg C. Fonarow, MD; Mihai Gheorghiade, MD
JAMA. 2013;309(15):1593-1594. doi:10.1001/jama.2013.1063.
Research Letters |  April 17, 2013
Long-term Outcomes of Left Anterior Fascicular Block in the Absence of Overt Cardiovascular Disease
Mala C. Mandyam, BS; Elsayed Z. Soliman, MD; Susan R. Heckbert, MD, PhD; et al.
JAMA. 2013;309(15):1587-1588. doi:10.1001/jama.2013.2729.
Preliminary Communication |  April 17, 2013
Effect of Shock Wave–Facilitated Intracoronary Cell Therapy on LVEF in Patients With Chronic Heart Failure:  The CELLWAVE Randomized Clinical Trial
Birgit Assmus, MD; Dirk H. Walter, MD; Florian H. Seeger, MD; et al.
JAMA. 2013;309(15):1622-1631. doi:10.1001/jama.2013.3527.
INCLUDES: , Supplemental Content
Original Contribution |  April 03, 2013
Mortality Rates for Medicare Beneficiaries Admitted to Critical Access and Non–Critical Access Hospitals, 2002-2010
Karen E. Joynt, MD, MPH; E. John Orav, PhD; Ashish K. Jha, MD, MPH
JAMA. 2013;309(13):1379-1387. doi:10.1001/jama.2013.2366.
INCLUDES: , Supplemental Content
Original Contribution |  March 27, 2013
Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction:  A Randomized Clinical Trial
Margaret M. Redfield, MD; Horng H. Chen, MD; Barry A. Borlaug, MD; et al.
JAMA. 2013;309(12):1268-1277. doi:10.1001/jama.2013.2024.
INCLUDES: , Supplemental Content
Original Contribution |  March 20, 2013
Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure:  The ASTRONAUT Randomized Trial
Mihai Gheorghiade, MD; Michael Böhm, MD; Stephen J. Greene, MD; et al.
JAMA. 2013;309(11):1125-1135. doi:10.1001/jama.2013.1954.
INCLUDES: , Supplemental Content
Editorial |  March 06, 2013
Cardiovascular Imaging in Clinical Practice:  What Does Late Gadolinium Enhance?
Deepak K. Gupta, MD; Raymond Y. Kwong, MD, MPH; Marc A. Pfeffer, MD, PhD
JAMA. 2013;309(9):929-930. doi:10.1001/jama.2013.1806.
Original Contribution |  March 06, 2013
Association of Fibrosis With Mortality and Sudden Cardiac Death in Patients With Nonischemic Dilated Cardiomyopathy
Ankur Gulati, MD; Andrew Jabbour, MD, PhD; Tevfik F. Ismail, MD; et al.
JAMA. 2013;309(9):896-908. doi:10.1001/jama.2013.1363.
INCLUDES: , Supplemental Content
Editorial |  February 27, 2013
Defining Diastolic Heart Failure and Identifying Effective Therapies
John G. F. Cleland, MD, PhD, FRCP; Pierpaolo Pellicori, MD
JAMA. 2013;309(8):825-826. doi:10.1001/jama.2013.1569.
Original Contribution |  February 27, 2013
Effect of Spironolactone on Diastolic Function and Exercise Capacity in Patients With Heart Failure With Preserved Ejection Fraction:  The Aldo-DHF Randomized Controlled Trial
Frank Edelmann, MD; Rolf Wachter, MD; Albrecht G. Schmidt, MD; et al.
JAMA. 2013;309(8):781-791. doi:10.1001/jama.2013.905.
INCLUDES: , Supplemental Content
Original Contribution |  February 13, 2013
Relationship Between Hospital Readmission and Mortality Rates for Patients Hospitalized With Acute Myocardial Infarction, Heart Failure, or Pneumonia
Harlan M. Krumholz, MD, SM; Zhenqiu Lin, PhD; Patricia S. Keenan, PhD, MHS; et al.
JAMA. 2013;309(6):587-593. doi:10.1001/jama.2013.333.
Editorial |  January 23, 2013
Revisiting Hospital Readmissions
Phil B. Fontanarosa, MD, MBA; Robert A. McNutt, MD
JAMA. 2013;309(4):398-400. doi:10.1001/jama.2013.42.
Original Contribution |  January 23, 2013
Diagnoses and Timing of 30-Day Readmissions After Hospitalization for Heart Failure, Acute Myocardial Infarction, or Pneumonia
Kumar Dharmarajan, MD, MBA; Angela F. Hsieh, PhD; Zhenqiu Lin, PhD; et al.
JAMA. 2013;309(4):355-363. doi:10.1001/jama.2012.216476.
INCLUDES: CME , Supplemental Content
Viewpoint |  January 23, 2013
Thirty-Day Readmissions:  The Clock Is Ticking
Muthiah Vaduganathan, MD, MPH; Robert O. Bonow, MD, MS; Mihai Gheorghiade, MD
JAMA. 2013;309(4):345-346. doi:10.1001/jama.2012.205110.
INCLUDES: , Supplemental Content
Preliminary Communication |  December 12, 2012
Comparison of Allogeneic vs Autologous Bone Marrow–Derived Mesenchymal Stem Cells Delivered by Transendocardial Injection in Patients With Ischemic Cardiomyopathy:  The POSEIDON Randomized Trial
Joshua M. Hare, MD; Joel E. Fishman, MD, PhD; Gary Gerstenblith, MD; et al.
JAMA. 2012;308(22):2369-2379. doi:10.1001/jama.2012.25321.
INCLUDES: , Supplemental Content
Editorial |  December 12, 2012
Mixed Results for Bone Marrow–Derived Cell Therapy for Ischemic Heart Disease
Eduardo Marbán, MD, PhD; Konstantinos Malliaras, MD
JAMA. 2012;308(22):2405-2406. doi:10.1001/jama.2012.64751.
Editorial |  November 28, 2012
Heart Failure Therapy:  What Should Clinicians Believe?
James C. Fang, MD
JAMA. 2012;308(20):2144-2146. doi:10.1001/jama.2012.45418.
Original Contribution |  November 28, 2012 FREE
Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction
Lars H. Lund, MD, PhD; Lina Benson, MSc; Ulf Dahlström, MD, PhD; et al.
JAMA. 2012;308(20):2108-2117. doi:10.1001/jama.2012.14785.
INCLUDES: , Supplemental Content
Original Contribution |  November 28, 2012 FREE
Associations Between Aldosterone Antagonist Therapy and Risks of Mortality and Readmission Among Patients With Heart Failure and Reduced Ejection Fraction
Adrian F. Hernandez, MD, MHS; Xiaojuan Mi, PhD; Bradley G. Hammill, MS; et al.
JAMA. 2012;308(20):2097-2107. doi:10.1001/jama.2012.14795.
INCLUDES: , Supplemental Content
Original Contribution |  August 01, 2012 FREE
Effects of Exercise Training on Depressive Symptoms in Patients With Chronic Heart Failure:  The HF-ACTION Randomized Trial
James A. Blumenthal, PhD; Michael A. Babyak, PhD; Christopher O’Connor, MD; et al.
JAMA. 2012;308(5):465-474. doi:10.1001/jama.2012.8720.
INCLUDES: , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  April 22, 2013
Nullius In Verba:  Don't Take Anyone's Word for It
Richard S. Lehman, MA, BM,  BCh, MRCGP
JAMA Internal Medicine
Research Letters  |  Mar 25, 2013
Variation in Medication Adherence in Heart Failure
Yuting Zhang, PhD; Shang-Hua Wu, MS; A. Mark Fendrick, MD; et al.
JAMA Internal Medicine
Invited Commentary  |  Mar 11, 2013
Defibrillators, Deactivation, Decisions, and Dying :  Comment on “Patient Preferences for Deactivation of Implantable Cardioverter-Defibrillators”
Dan D. Matlock, MD, MPH; Larry A. Allen, MD, MHS
JAMA Neurology
Observation  |  Feb 2013
Mitochondrial Cardioencephalomyopathy Due to a Novel SCO2 Mutation in a Brazilian Patient:  Case Report and Literature Review
Juliana Gurgel-Giannetti, MD, PhD; Guilherme Oliveira, PhD; Geraldo Brasileiro Filho, MD, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems